Showing results (131-140 of 178) with videos related to
Sort By:
Pageof 18
Journal of Cancer Survivorship : Research and Practice|May 4, 2023
Late-onset vascular complications of radiotherapy for primary brain tumors: a case-control and cross-sectional analysisMaría-José Ibáñez-Juliá, Alberto Picca, Delphine Leclercq, et al.Oncoimmunology|June 27, 2013
The natural killer cell response and tumor debulking are associated with prolonged survival in recurrent glioblastoma patients receiving dendritic cells loaded with autologous tumor lysatesSerena Pellegatta, Marica Eoli, Simona Frigerio, et al.Cancer Research|June 29, 2012
The MET oncogene is a functional marker of a glioblastoma stem cell subtypeFrancesca De Bacco, Elena Casanova, Enzo Medico, et al.Neurology(R) Neuroimmunology & Neuroinflammation|February 27, 2021
Longitudinally Extensive Myelitis Associated With Immune Checkpoint InhibitorsAlberto Picca, Giulia Berzero, Kevin Bihan, et al.Neuro-Oncology|November 11, 2020
IDH-wildtype lower-grade diffuse gliomas: the importance of histological grade and molecular assessment for prognostic stratificationGiulia Berzero, Anna Luisa Di Stefano, Susanna Ronchi, et al.Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|June 25, 2026
Mapping integrated care for brain tumour-related epilepsy in the Italian RIN-IRCCS networkElena Anghileri, Alessia Marcassoli, Veronica Villani, et al.Neurology(R) Neuroimmunology & Neuroinflammation|April 13, 2021
Clinical and Prognostic Value of Immunogenetic Characteristics in Anti-LGI1 EncephalitisSergio Muñiz-Castrillo, Julie Haesebaert, Laure Thomas, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 23, 2006
Identification of tumor-specific molecular signatures in intracranial ependymoma and association with clinical characteristicsPiergiorgio Modena, Elena Lualdi, Federica Facchinetti, et al.Nature Medicine|December 12, 2018
The molecular landscape of glioma in patients with Neurofibromatosis 1Fulvio D'Angelo, Michele Ceccarelli, Tala, et al.Cell Reports|July 28, 2021
ERBB3 overexpression due to miR-205 inactivation confers sensitivity to FGF, metabolic activation, and liability to ERBB3 targeting in glioblastomaFrancesca De Bacco, Francesca Orzan, Jessica Erriquez, et al.Pageof 18